drugset / Trial / NCT02280850

Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina

NCT02280850

Phase 4 Unknown 300 enrolled Shaanxi Buchang Pharmaceutical Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Compared with placebo, assess of the efficacy and safety of Guanxin Shutong capsule to treat chronic stable angina (syndrome of blood stasis resistance), and the result will be used for the basis of later Ⅳ clinical trial.

Timeline

Start
2014-10
Primary completion
2015-06
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Guanxinshutong Unknown 3 unknown Oral
Background nitroglycerine Unknown 0.25 mg Other
Background nitroglycerine Unknown 0.5 mg Other